These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 7502518

  • 1. [Evaluation of the antihypertensive drugs carvedilol, doxazosin and moxonidine].
    Dominiak P.
    Wien Med Wochenschr; 1995; 145(15-16):373-82. PubMed ID: 7502518
    [Abstract] [Full Text] [Related]

  • 2. [Balanced beta--alpha-blocker treatment with carvedilol in mild-moderate arterial hypertension].
    Perocchio M, Gigli G, Barra M, Sacchetti R, Vallebona A, Rosolen GA, Orlandi S.
    Minerva Cardioangiol; 1996 Mar; 44(3):115-21. PubMed ID: 8767610
    [Abstract] [Full Text] [Related]

  • 3. Clinical experience with dual-acting drugs in hypertension.
    Rahn KH.
    Clin Investig; 1992 Mar; 70 Suppl 1():S39-42. PubMed ID: 1350483
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A, Heidland A, Pangerl A, Meyer-Sabellek W, Schaefer RM.
    Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
    [Abstract] [Full Text] [Related]

  • 6. Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
    Omvik P, Lund-Johansen P.
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):193-206. PubMed ID: 8395198
    [Abstract] [Full Text] [Related]

  • 7. Preclinical and clinical pharmacology of carvedilol.
    Ruffolo RR, Boyle DA, Venuti RP, Lukas MA.
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S2-15. PubMed ID: 8487245
    [Abstract] [Full Text] [Related]

  • 8. Adrenoreceptors, endothelial function, and lipid profile: effects of atenolol, doxazosin, and carvedilol.
    González Maqueda I.
    Coron Artery Dis; 1994 Nov; 5(11):909-18. PubMed ID: 7719523
    [Abstract] [Full Text] [Related]

  • 9. Carvedilol in the treatment of hypertension--a review of the clinical data base.
    Hansson L, Himmelmann A.
    Scand Cardiovasc J Suppl; 1998 Nov; 47():67-80. PubMed ID: 9540136
    [Abstract] [Full Text] [Related]

  • 10. The role of alpha- and beta-adrenoceptor blockade in antihypertensive treatment.
    van Zwieten PA.
    Clin Investig; 1992 Nov; 70 Suppl 1():S7-12. PubMed ID: 1350488
    [Abstract] [Full Text] [Related]

  • 11. Effective antihypertensive therapy: blood pressure control with moxonidine.
    Prichard BN, Graham BR.
    J Cardiovasc Pharmacol; 1996 Nov; 27 Suppl 3():S38-48. PubMed ID: 8872298
    [Abstract] [Full Text] [Related]

  • 12. Carvedilol: a third-generation β-blocker should be a first-choice β-blocker.
    DiNicolantonio JJ, Hackam DG.
    Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):13-25. PubMed ID: 22149523
    [Abstract] [Full Text] [Related]

  • 13. Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction.
    Frishman WH, Henderson LS, Lukas MA.
    Vasc Health Risk Manag; 2008 Jan; 4(6):1387-400. PubMed ID: 19337551
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Carvedilol].
    Antepohl W, Herzig S, Böhm M.
    Dtsch Med Wochenschr; 1997 Jun 20; 122(25-26):833-4. PubMed ID: 9244672
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of carvedilol in older and younger patients.
    Morgan T, Anderson A, Cripps J, Adam W.
    J Hum Hypertens; 1990 Dec 20; 4(6):709-15. PubMed ID: 2096213
    [Abstract] [Full Text] [Related]

  • 17. Central I1-imidazoline receptors as targets of centrally acting antihypertensive drugs. Clinical pharmacology of moxonidine and rilmenidine.
    Van Zwieten PA, Peters SL.
    Ann N Y Acad Sci; 1999 Jun 21; 881():420-9. PubMed ID: 10415946
    [Abstract] [Full Text] [Related]

  • 18. Pharmacodynamic profile of carvedilol.
    van Zwieten PA.
    Cardiology; 1993 Jun 21; 82 Suppl 3():19-23. PubMed ID: 8106159
    [Abstract] [Full Text] [Related]

  • 19. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN, Owens CW, Graham BR.
    J Hum Hypertens; 1997 Aug 21; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.